From concept to completion: The Cancer Research UK Clinical Trials Unit (CRCTU) quickly and safely translates cutting-edge science into improved patient care. It achieves this through its expertise in the design, methodology and conduct of large multi-centre, international, randomised trials – as well as smaller more data intensive phase I trials of novel therapies.
The CRCTU has more than 30 years’ experience of running academic and pharmaceutical clinical trials. It is one of the largest clinical trials units in the United Kingdom. The CRCTU was one of the first National Cancer Research Institute accredited clinical trials units and is a UKCRN registered unit.
CRCTU has six trial management teams specialising in: adult cancer early drug development; early and late (randomised) phase cancer paediatric trials; early phase haemato-oncology trials; adult cancer late phase trials; and early phase non-cancer trials.
It also collaborates with a large number of Investigators both at a national and international level and welcomes enquiries from investigators wishing to work with the CRCTU team.